Literature DB >> 22161162

Discordance among commercially available diagnostics for latent tuberculosis infection.

James D Mancuso1, Gerald H Mazurek, David Tribble, Cara Olsen, Naomi E Aronson, Lawrence Geiter, Donald Goodwin, Lisa W Keep.   

Abstract

RATIONALE: There is uncertainty regarding how to interpret discordance between tests for latent tuberculosis infection.
OBJECTIVES: The objective of this study was to assess discordance between commercially available tests for latent tuberculosis in a low-prevalence population, including the impact of nontuberculous mycobacteria.
METHODS: This was a cross-sectional comparison study among 2,017 military recruits at Fort Jackson, South Carolina, from April to June 2009. Several tests were performed simultaneously with a risk factor questionnaire, including (1) QuantiFERON-TB Gold In-Tube test, (2) T-SPOT.TB test, (3) tuberculin skin test, and (4) Battey skin test using purified protein derivative from the Battey bacillus.
MEASUREMENTS AND MAIN RESULTS: In this low-prevalence population, the specificities of the three commercially available diagnostic tests were not significantly different. Of the 88 subjects with a positive test, only 10 (11.4%) were positive to all three tests; 20 (22.7%) were positive to at least two tests. Bacille Calmette-Guérin vaccination, tuberculosis prevalence in country of birth, and Battey skin test reaction size were associated with tuberculin skin test-positive, IFN-γ release assay-negative test discordance. Increasing agreement between the three tests was associated with epidemiologic criteria indicating risk of infection and with quantitative test results.
CONCLUSIONS: For most positive results the three tests identified different people, suggesting that in low-prevalence populations most discordant results are caused by false-positives. False-positive tuberculin skin test reactions associated with reactivity to nontuberculous mycobacteria and bacille Calmette-Guérin vaccination may account for a proportion of test discordance observed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22161162      PMCID: PMC3297098          DOI: 10.1164/rccm.201107-1244OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  37 in total

1.  Frost revisited: the modern epidemiology of tuberculosis.

Authors:  G W Comstock
Journal:  Am J Epidemiol       Date:  1975-05       Impact factor: 4.897

2.  Risk factors associated with tuberculin skin test positivity among university students and the use of such factors in the development of a targeted screening program.

Authors:  Venkatarama Rao Koppaka; Eric Harvey; Beth Mertz; Betty Anne Johnson
Journal:  Clin Infect Dis       Date:  2003-02-17       Impact factor: 9.079

3.  Tuberculin skin tests: atypical mycobacterial PPD-Battey skin test conversion following airborne training.

Authors:  A M Margileth; J N Longfield; S M Golden; S Lazoritz; J S Bohan
Journal:  Mil Med       Date:  1986-12       Impact factor: 1.437

4.  Evaluation of the clinical usefulness of mycobacterial skin test antigens in adults with pulmonary mycobacterioses.

Authors:  R E Huebner; M F Schein; G M Cauthen; L J Geiter; M J Selin; R C Good; R J O'Brien
Journal:  Am Rev Respir Dis       Date:  1992-05

5.  Identification of tuberculous infected. Dual tests and density of reaction.

Authors:  L B Edwards; F A Acquaviva; V T Livesay
Journal:  Am Rev Respir Dis       Date:  1973-12

6.  Tuberculin dual testing in Panama.

Authors:  W F Larrabee; R Talarera
Journal:  Tubercle       Date:  1980-12

7.  Targeted testing of children for tuberculosis: validation of a risk assessment questionnaire.

Authors:  H Froehlich; L M Ackerson; P A Morozumi
Journal:  Pediatrics       Date:  2001-04       Impact factor: 7.124

8.  Usefulness of skin testing with mycobacterial antigens in children with cervical lymphadenopathy.

Authors:  R E Huebner; M F Schein; G M Cauthen; L J Geiter; R J O'Brien
Journal:  Pediatr Infect Dis J       Date:  1992-06       Impact factor: 2.129

9.  [Tuberculin sensitivity to purified protein derivatives (PPD) from M. intracellulare (PPD-B), M. kansasii (PPD-Y), M. fortuitum (PPD-Y) and M. tuberculosis (PPDs) among healthy volunteers].

Authors:  E Shigeto; H Tasaka
Journal:  Kekkaku       Date:  1993-04

10.  The use of purified protein derivative mycobacterial skin test antigens in children and adolescents: purified protein derivative skin test results correlated with mycobacterial isolates.

Authors:  A M Margileth
Journal:  Pediatr Infect Dis       Date:  1983 May-Jun
View more
  16 in total

1.  Diagnosis and treatment of latent tuberculosis infection: an update.

Authors:  Anna K Person; April C Pettit; Timothy R Sterling
Journal:  Curr Respir Care Rep       Date:  2013-12

2.  A cough conundrum in a patient with a previous history of BCG immunotherapy for bladder cancer.

Authors:  Arpan R Mehta; Puja R Mehta; Rajesh L Mehta
Journal:  BMJ Case Rep       Date:  2012-10-24

3.  A new cytokine release assay: a simple approach to monitor the immune status of HIV-infected patients.

Authors:  I Kaufmann; R Draenert; M Gruber; M Feuerecker; J Roider; A Choukèr
Journal:  Infection       Date:  2013-03-28       Impact factor: 3.553

4.  Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice.

Authors:  John Z Metcalfe; Adithya Cattamanchi; Charles E McCulloch; Justin D Lew; Ngan P Ha; Edward A Graviss
Journal:  Am J Respir Crit Care Med       Date:  2012-10-26       Impact factor: 21.405

5.  Challenges in Obtaining Estimates of the Risk of Tuberculosis Infection During Overseas Deployment.

Authors:  James D Mancuso; Mia Geurts
Journal:  Am J Trop Med Hyg       Date:  2015-09-28       Impact factor: 2.345

6.  Dynamic QuantiFERON Response in Psoriasis Patients Taking Long-Term Biologic Therapy.

Authors:  Lorenzo Drago; Lucia Nicola; Valentina Signori; Elisa Palazzi; Cecilia Garutti; Samantha Spadino; Gianfranco Altomare
Journal:  Dermatol Ther (Heidelb)       Date:  2013-02-23

7.  Broad adaptive immune responses to M. tuberculosis antigens precede TST conversion in tuberculosis exposed household contacts in a TB-endemic setting.

Authors:  Ulrike K Buchwald; Ifedayo M O Adetifa; Christian Bottomley; Patrick K Owiafe; Simon Donkor; Adama L Bojang; Jayne S Sutherland
Journal:  PLoS One       Date:  2014-12-30       Impact factor: 3.240

8.  Screening for latent tuberculosis before starting TNF-alpha inhibitors in a population with high BCG vaccination rates.

Authors:  Aysa Hacioglu; Sermin Borekci; Melike Melikoglu; Yesim Ozguler; Sinem Nihal Esatoglu; Serdal Ugurlu; Emire Seyahi; Izzet Fresko; Vedat Hamuryudan; Huri Ozdogan; Sebahattin Yurdakul; Ibrahim Hatemi; Aykut Ferhat Celik; H Gul Ongen; Gulen Hatemi
Journal:  Rheumatol Int       Date:  2021-07-06       Impact factor: 3.580

9.  Discordance of tuberculin skin test and interferon gamma release assay in recently exposed household contacts of pulmonary TB cases in Brazil.

Authors:  Rodrigo Ribeiro-Rodrigues; Soyeon Kim; Flávia Dias Coelho da Silva; Aleksandra Uzelac; Lauren Collins; Moíses Palaci; David Alland; Reynaldo Dietze; Jerrold J Ellner; Edward Jones-López; Padmini Salgame
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

10.  Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.

Authors:  Matthew K O'Shea; Thomas E Fletcher; Nicholas J Beeching; Martin Dedicoat; David Spence; Helen McShane; Adam F Cunningham; Duncan Wilson
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.